SEC Form 4 · accession 0001127602-15-011892
ARIAD PHARMACEUTICALS INC · ARIA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel M Bollag
Officer — Sr. VP, Reg. Affairs & Quality
Period of report
Mar 16, 2015
Accepted (ET)
Mar 18, 2015 · 4:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000884731
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 16, 2015 | M | 7,500 | $1.30 | A | 145,222 | D | |
| Common Stock | Mar 16, 2015 | S | 7,500 | $8.6173 | D | 137,722 | D | |
| Common Stock | Mar 16, 2015 | S | 26,925 | $8.6173 | D | 110,797 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $1.30 | Mar 16, 2015 | M | 7,500 | D | — | Mar 10, 2019 | Common Stock | 7,500 | 3,750 | D |
Explanation of responses
- F1Options vest 25% per year on each March 10, 2010, 2011, 2012 and 2013.